Helen Torley | President, Chief Executive Officer |
Al Kildani | Vice President of Investor Relations and Corporate Communications |
Charles Duncan | Cantor Fitzgerald |
Jason Butler | JMP Securities |
Jim Birchenough | Wells Fargo |
Jessica Fye | JP Morgan |
Graig Suvannavejh | Goldman Sachs |
Joe Catanzaro | Piper Sandler |
Joel Beatty | Citi |
Gena Wang | Barclays |
Ben Shim | Canaccord |
Ladies and gentlemen, thank you for standing by and welcome to the Halozyme, Fourth Quarter 2019 Financial Results Webcast and Conference Call. At this time all participants’ lines are in a listen-only mode. [Operator Instructions] Please be advised that today’s conference is being recorded. [Operator Instructions].
I would now like to turn the conference over to Al Kildani, Vice President of Investor Relations and Corporate Communications for Halozyme Therapeutics.